Skip to main content

RHUMBLINE ADVISERS

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1115418 BOSTON, MA

Position in XERS

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,108,188
-$379,912 QoQ
Shares Held
191,067
+0.8% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 21.0878906352222.ToString("F0")% Shared 0.ToString("F0")% None 78.9121093647778.ToString("F0")%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. XERS ranks #26 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,108,188 191,067
2025-12-31 $1,488,100 189,567
2025-09-30 $1,739,876 213,744
2025-06-30 $1,007,276 215,691
2025-03-31 $1,055,622 192,281
2024-12-31 $613,467 180,964
2024-09-30 $494,634 173,556
2024-06-30 $427,432 189,970
2024-03-31 $392,579 177,638
2023-12-31 $402,536 171,292
2023-09-30 $323,282 173,808
2023-06-30 $455,589 173,889
2023-03-31 $281,747 172,851
2022-12-31 $220,595 165,861
2022-09-30 $253,836 162,716
2022-06-30 $233,485 151,614